US covid outbreak uncontrolled throughout all states


  • Nearly every US state is now classified as having an uncontrolled spread of the virus.
  • Investors positioning for prolonged fiscal stimulus measures and move away from economically growth-sensitive stocks. 

The trajectory of the US coronavirus spread has been going from bad to worse in recent weeks with new cases surging across all states of America. 

Texas has just become the first state to hit one million in total cases.

Other states, including Illinois, Wisconsin, Minnesota, California and Florida, have also seen numbers rise.

CBS News reports 15 states saw the numbers of patients in the hospital due to the virus double in the last month.

According to a study by covidexitstrategy.org, nearly every US state is now classified as having an uncontrolled spread of the virus.  

While Americans' attention has been centred on the outcome of the presidential election, the country quietly hit a grim milestone, marking a record-breaking 102,831 last week in new COVID-19 infections for a single day.

Update: 144,000 new confirmed cases 11/11/2020. 

The US has been seeing more than 100,000 new cases per day over the last 10 days in what experts say may be a worse outbreak than those seen in the spring and summer.

There are now over some 10 million confirmed US cases and 239,732 deaths so far.

The death toll is moving up to an average of over 900 a day and experts have warned hospitals across the country could soon be overwhelmed.

The Wall Street Journal has written that New York will set a 10 p.m. curfew for most bars and restaurants and will limit gatherings at private residences to 10 people as the number of novel coronavirus cases and hospitalizations continued to rise around the state.

The Democratic governor, Gov. Andrew Cuomo said Wednesday, has been reported by the WSJ to have also said gyms must close by 10 p.m. The new restrictions take effect on Friday.

''Mr. Cuomo said private gatherings, bars, restaurants and gyms have been a source of increase for the virus, which killed 21 New Yorkers on Tuesday.''

Meanwhile, the US infectious disease chief Dr Anthony Fauci offered some hopeful news.

He said the new Covid vaccine by Pfizer, which in human trials suggest it is 90% effective, was expected to go through an emergency authorisation process in the next week or so.

Welcomed news of the vaccine wearing off

As for the markets, the welcomed news of the vaccine has started to wear off as we have seen investors move back into the technology and away from economically sensitive sectors.

At 2:40 p.m. EST, the Dow Jones Industrial Average was losing 62.24 points, or 0.21%, to 29,358.68 and the Nasdaq Composite added 201.66 points, or 1.75%, to 11,755.51.

The US dollar's relief rally is also coming under pressure as markets prepare for prolonged fiscal stimulus measures:

 

 

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Recommended content


Recommended content

Editors’ Picks

EUR/USD clings to gains near 1.0700, eyes on key US data

EUR/USD clings to gains near 1.0700, eyes on key US data

EUR/USD clings to gains near the 1.0700 level in early Europe on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data. 

EUR/USD News

USD/JPY finds its highest bids since 1990, near 155.50

USD/JPY finds its highest bids since 1990, near 155.50

USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, testing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming Japanese intervention risks. Focus shifts to Thursday's US GDP report and the BoJ decision on Friday. 

USD/JPY News

Gold price lacks firm intraday direction, holds steady above $2,300 ahead of US data

Gold price lacks firm intraday direction, holds steady above $2,300 ahead of US data

Gold price remains confined in a narrow band for the second straight day on Thursday. Reduced Fed rate cut bets and a positive risk tone cap the upside for the commodity. Traders now await key US macro data before positioning for the near-term trajectory.

Gold News

Injective price weakness persists despite over 5.9 million INJ tokens burned

Injective price weakness persists despite over 5.9 million INJ tokens burned

Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price. Coupled with broader market gloom, INJ token’s doomed days may not be over yet.

Read more

Meta Platforms Earnings: META sinks 10% on lower Q2 revenue guidance Premium

Meta Platforms Earnings: META sinks 10% on lower Q2 revenue guidance

This must be "opposites" week. While Doppelganger Tesla rode horrible misses on Tuesday to a double-digit rally, Meta Platforms produced impressive beats above Wall Street consensus after the close on Wednesday, only to watch the share price collapse by nearly 10%.

Read more

Forex MAJORS

Cryptocurrencies

Signatures